Myomo (MYO) EPS (Basic) Growth (3y) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -6.15% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 7.72% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -1.10% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 62.43% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.44% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 58.74% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 26.49% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 5.98% |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 39.18% |
| Jun 30, 2025 | 36.02% |
| Mar 31, 2025 | 42.00% |
| Dec 31, 2024 | 54.18% |
| Sep 30, 2024 | 56.32% |
| Jun 30, 2024 | 59.75% |
| Mar 31, 2024 | 44.02% |
| Dec 31, 2023 | -20.51% |
| Sep 30, 2023 | 55.91% |
| Jun 30, 2023 | 67.07% |
| Mar 31, 2023 | 64.74% |
| Dec 31, 2022 | 61.22% |
| Sep 30, 2022 | 56.53% |
| Jun 30, 2022 | 54.64% |
| Mar 31, 2022 | 60.83% |
| Dec 31, 2021 | 72.51% |
| Sep 30, 2021 | -19.68% |
| Jun 30, 2021 | -29.87% |
| Mar 31, 2021 | -41.78% |
| Dec 31, 2020 | -27.87% |
| Sep 30, 2020 | -49.38% |
| Jun 30, 2020 | 30.59% |
| Mar 31, 2020 | -17.43% |
| Dec 31, 2019 | -55.77% |
| Sep 30, 2019 | -64.70% |
| Jun 30, 2019 | -68.54% |